Mark Thompson

Title: Mark Thompson: Innovator in Cell Culture and Virus Propagation

Introduction

Mark Thompson is a notable inventor based in Morgan Hill, CA (US). He has made significant contributions to the field of cell culture and virus propagation, holding a total of 5 patents. His work focuses on developing methods that enhance the cultivation and purification of viruses, particularly influenza viruses.

Latest Patents

Thompson's latest patents include innovative methods for cultivating cells, propagating, and purifying viruses. One of his key inventions provides a novel serum-free cell culture medium and methods for cultivating non-tumorigenic MDCK cells. This invention also outlines methods for producing influenza viruses that eliminate the need for a cell culture medium exchange step. The novel medium and methods are designed to grow influenza viruses in cell culture to high titers. Furthermore, his patents detail purification methods that achieve high overall recovery of live virus while ensuring that levels of host cell DNA, host cell protein, and non-specific endonuclease are below regulatory specifications.

Another significant patent involves MDCK cell lines that support viral growth to higher titers than previously possible. These MDCK cells can be adapted to serum-free culture medium, and the invention includes cell culture compositions and cultivation methods for growing these cells.

Career Highlights

Throughout his career, Mark Thompson has worked with prominent companies in the biotechnology sector, including Medimmune Limited and Memimmune, LLC. His experience in these organizations has contributed to his expertise in the field of viral research and cell culture technologies.

Collaborations

Thompson has collaborated with notable colleagues such as Jonathan Edward Liu and Luis J Maranga, further enhancing his contributions to the field.

Conclusion

Mark Thompson's innovative work in cell culture and virus propagation has led to significant advancements in the biotechnology industry. His patents reflect a commitment to improving methods for cultivating and purifying viruses, which can have a profound impact on vaccine development and therapeutic applications.